Haemonetics Corporation HAE
120.27 USD +0.13 (+0.11%)
At closeNov 3, 2026, 4:00 PM EST
120.28 +0.01 +0.01%
After hours · Nov 3, 4:00 PM ET
119.00 Day range 121.44
49.96 52-week range 123.77
- YTD
- +50.06%
- 1 year
- +139.25%
Analyst view
Consensus: buy
Buy
Price target (mean) 124.50 +3.5% upside
Now 120.27
- Target (low)
- 86.00
- Target (mean)
- 124.50
- Target (high)
- 142.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
- Strong buy4
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.29 | 1.21 – 1.37 | 1.27 | +1.7% | 345.15M | +5.5% | 11 |
| Next quarter | 1.36 | 1.25 – 1.43 | 1.31 | +3.7% | 357.56M | +5.5% | 11 |
| Current year | 5.31 | 5.25 – 5.40 | 4.96 | +7.0% | 1.42B | +6.2% | 11 |
| Next year | 5.78 | 5.47 – 6.18 | 5.31 | +8.8% | 1.50B | +5.5% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 9, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 8, 2026 | BTIG | Maintained | Buy | Buy |
| Sep 17, 2026 | Citigroup | Upgrade | Neutral | Buy |
| Sep 3, 2026 | Raymond James | Maintained | Outperform | Outperform |
| Aug 21, 2026 | Baird | Maintained | Outperform | Outperform |
| Aug 19, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 18, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 7, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 6, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 26, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 17, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 28, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 22, 2026 | B of A Securities | Upgrade | Neutral | Buy |
| May 12, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| May 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 13, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Apr 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Mar 11, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 6, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 6, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 6, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 6, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 2, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jan 12, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jan 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Dec 17, 2025 | Mizuho | Maintained | Outperform | Outperform |
